Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, par value 0.00001 NIS per share
-
Shares outstanding
-
240M
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
111M
-
Shares change
-
+1.32M
-
Total reported value, excl. options
-
$2.16B
-
Value change
-
+$17.3M
-
Put/Call ratio
-
0.48
-
Number of buys
-
109
-
Number of sells
-
-100
-
Price
-
$19.43
Significant Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) as of Q1 2025
240 filings reported holding CLBT - Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share as of Q1 2025.
Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 111M shares
of 240M outstanding shares and own 46.22% of the company stock.
Largest 10 shareholders include True Wind Capital Management, L.P. (13.9M shares), FMR LLC (9.93M shares), AXON ENTERPRISE, INC. (9M shares), MORGAN STANLEY (3.96M shares), ACADIAN ASSET MANAGEMENT LLC (3.92M shares), Voss Capital, LP (3.84M shares), Clal Insurance Enterprises Holdings Ltd (3.34M shares), Invesco Ltd. (3.3M shares), T. Rowe Price Investment Management, Inc. (3.14M shares), and BlackRock, Inc. (2.66M shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.